|
|
|
Volumn 8, Issue 5, 2002, Pages 1310-1313
|
|
A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FENRETINIDE;
PLACEBO;
ANTINEOPLASTIC AGENT;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG MONITORING;
FOOD COMPOSITION;
FOOD DRUG INTERACTION;
HUMAN;
LETTER;
MULTICENTER STUDY;
PRIORITY JOURNAL;
SQUAMOUS CELL CARCINOMA;
UTERINE CERVIX CARCINOMA IN SITU;
BLOOD;
CONTROLLED CLINICAL TRIAL;
FEMALE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
UTERINE CERVIX TUMOR;
ANTINEOPLASTIC AGENTS;
CERVICAL INTRAEPITHELIAL NEOPLASIA;
FEMALE;
FENRETINIDE;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
UTERINE CERVICAL NEOPLASMS;
|
|
EID: 0036097191
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (4)
|
|
References (0)
|